Esperion Therapeutics (ESPR) P/E (2014 - 2026)
Esperion Therapeutics (ESPR) P/E from Dec 31, 2014 to Jul 13, 2026. The TTM Esperion Therapeutics (ESPR) P/E is -6.03. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Esperion Therapeutics (ESPR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -6.03 | -5.71% |
| 2025 | -6.40 | +41.85% |
| 2024 | -4.51 | +265.98% |
| 2023 | -1.23 | +7.15% |
| 2022 | -1.15 | +149.73% |
| 2021 | -0.46 | -93.50% |
| 2020 | -7.08 | -58.10% |
| 2019 | -16.91 | +176.79% |
| 2018 | -6.11 | -37.62% |
| 2017 | -9.79 | +105.18% |
| 2016 | -4.77 | -52.55% |
| 2015 | -10.06 | -88.43% |
| 2014 | -86.96 | N/A |
Comparison Esperion Therapeutics (ESPR) P/E with competitors
Esperion Therapeutics (ESPR) P/E is -6.03.